The 2024-25 annual report from the Pan-Canadian Cancer Genomics Community of Practice showcases achievements throughout the year and details next steps toward equitable, standardized biomarker testing.
Year: 2025
Members of the Pan-Canadian Cancer Genomics Community of Practice contributed to the development of a consensus-based assessment framework to support the standardized, efficient, and transparent evaluation of molecular, genetic, and genomic biomarkers in cancer care in Canada.
The pan-Canadian Quality Assurance in Radiopharmaceutical Therapy (pCQRT) advisory committee — one of CAPCA’s standing committees — recently met to set its upcoming priorities.
This marks the committee’s first multi-year work plan and outlines how pCQRT will help support safe,…
As the organization that brings together the leadership of all provincial cancer agencies and programs, the Canadian Association of Provincial Cancer Agencies with support from the Canadian Cancer Society has collaborated with member and partner organizations to assess cancer workforce…
Join the Pan-Canadian Cancer Data Strategy: Pan-Canadian RT Data Harmonization Project Webinar. There are two sessions to choose from.
